Center for Scientific Review; Notice of Closed Meetings, 56216-56217 [2012-22385]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
56216
Federal Register / Vol. 77, No. 177 / Wednesday, September 12, 2012 / Notices
Place: National Institutes of Health, 6120
Executive Boulevard, Room 511, Rockville,
MD 20852.
Contact Person: Thomas A. Winters, Ph.D.,
Scientific Review Officer, Special Review &
Logistics Branch, Division of Extramural
Activities, 6116 Executive Boulevard, Room
8146, National Cancer Institute, NIH,
Bethesda, MD 20892–8329, 301–594–1566,
twinters@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Quantitative Imaging for Evaluation of
Responses to Cancer Therapies.
Date: October 31, 2012.
Time: 10 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 611, Rockville,
MD 20852, (Telephone Conference Call).
Contact Person: Gerald G. Lovinger, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 8101
Bethesda, MD 20892–8329 301/496–7987
lovingeg@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Diagnostic and Therapeutic Agents Enabled
by Nanotechnology.
Date: November 27, 2012.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Boulevard, Room J, Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Savvas C. Makrides, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard., Room 8050A
Bethesda, MD 20892, 301–496–7421
makridessc@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: September 6, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–22384 Filed 9–11–12; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
18:51 Sep 11, 2012
Jkt 226001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Oncology 1-Basic
Translational Integrated Review Group;
Cancer Etiology Study Section.
Date: October 11, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Long Beach Hotel, 111
East Ocean Blvd., Long Beach, CA 90802.
Contact Person: Elaine Sierra-Rivera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7804, Bethesda, MD 20892, 301–435–
1779, riverase@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Integrative and Clinical Endocrinology and
Reproduction Study Section.
Date: October 11, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Dianne Hardy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6175,
MSC 7892, Bethesda, MD 20892, 301–435–
1154, dianne.hardy@nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group;
Gastrointestinal Mucosal Pathobiology Study
Section.
Date: October 11–12, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Peter J. Perrin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
MSC 7818, Bethesda, MD 20892, (301) 435–
0682, perrinp@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group; Cellular
Aspects of Diabetes and Obesity Study
Section.
Date: October 11–12, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Long Beach Hotel, 111
East Ocean Blvd., Long Beach, CA 90802.
Contact Person: Robert Garofalo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 6156,
MSC 7892, Bethesda, MD 20892, 301–435–
1043, garofalors@csr.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Biodata Management and Analysis
Study Section.
Date: October 11–12, 2012.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Bethesda, MD 20892.
Contact Person: Mark Caprara, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5156,
MSC 7844, Bethesda, MD 20892, 301–435–
1042, capraramg@mail.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Modeling and Analysis of Biological
Systems Study Section.
Date: October 11–12, 2012
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bolger Center, 9600 Newbridge
Drive, Potomac, MD 20854.
Contact Person: Craig Giroux, Scientific
Review Officer, BST IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5150,
Bethesda, MD 20892, 301–435–2204,
girouxcn@csr.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Neural Oxidative Metabolism
and Death Study Section.
Date: October 11–12, 2012.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Loews L’Enfant Plaza Hotel, 480
L’Enfant Plaza SW., Washington, DC 20024–
2197.
Contact Person: Carol Hamelink, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192,
MSC 7850, Bethesda, MD 20892, (301) 213–
9887, hamelinc@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Molecular and
Integrative Signal Transduction Study
Section.
Date: October 11–12, 2012.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\12SEN1.SGM
12SEN1
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 177 / Wednesday, September 12, 2012 / Notices
Place: Mayflower Park Hotel, 405 Olive
Way, Seattle, WA 98101.
Contact Person: Raya Mandler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5134,
MSC 7840, Bethesda, MD 20892, (301) 402–
8228, rayam@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Neurobiology of
Motivated Behavior Study Section.
Date: October 11, 2012.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: Spring Hill Suites New Orleans
Downtown, New Orleans, LA 70130.
Contact Person: Nicholas Gaiano, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5178, MSC 7844, Bethesda, MD
20892–7844, 301–435–1033,
gaianonr@csr.nih.gov.
Name of Committee: Immunology
Integrated Review Group; Vaccines Against
Microbial Diseases Study Section.
Date: October 11–12, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Marriott, 1221 22nd
Street NW., Washington, DC 20037.
Contact Person: Jian Wang, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4218,
MSC 7812, Bethesda, MD 20892, (301) 435–
2778, wangjia@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Mechanisms of
Sensory, Perceptual, and Cognitive Processes
Study Section.
Date: October 11–12, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Springhill Suites New Orleans
Downtown, 301 St. Joseph St, New Orleans,
LA 70130.
Contact Person: Kirk Thompson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5184,
MSC 7844, Bethesda, MD 20892, 301–435–
1242, kgt@mail.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Brain Injury and Neurovascular
Pathologies Study Section.
Date: October 11–12, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: New Orleans Marriott at the
Convention Center, 859 Convention Center
Boulevard, New Orleans, LA 70130.
Contact Person: Alexander Yakovlev,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5206,
MSC 7846, Bethesda, MD 20892, 301–435–
1254, yakovleva@csr.nih.gov.
Name of Committee: Oncology 1-Basic
Translational Integrated Review Group;
VerDate Mar<15>2010
18:51 Sep 11, 2012
Jkt 226001
Tumor Progression and Metastasis Study
Section.
Date: October 11–12, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Rolf Jakobi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187,
MSC 7806, Bethesda, MD 20892, 301–495–
1718, jakobir@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 6, 2012.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–22385 Filed 9–11–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–5603–N–62]
Notice of Submission of Proposed
Information Collection to OMB Disaster
Recovery Grant Reporting System
Office of the Chief Information
Officer, HUD
ACTION: Notice.
AGENCY:
The proposed information
collection requirement described below
has been submitted to the Office of
Management and Budget (OMB) for
review, as required by the Paperwork
Reduction Act. The Department is
soliciting public comments on the
subject proposal.
The Disaster Recovery Grant
Reporting (DRGR) System is a grants
management system used by the Office
of Community Planning and
Development to monitor special
appropriation grants under the
Community Development Block Grant
program. This collection pertains to
Community Development Block Grant
Disaster Recovery (CDBG–DR) and
Neighborhood Stabilization Program
(NSP) grant appropriations. The CDBG
program is authorized under Title I of
the Housing and Community
Development Act of 1974, as amended.
Following major disasters, Congress
appropriates supplemental CDBG funds
for disaster recovery. According to
Section 104(e)(1) of the Housing and
Community Development Act of 1974,
HUD is responsible for reviewing
grantees’ compliance with applicable
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
56217
requirements and their continuing
capacity to carry out their programs.
Grant funds are made available to states
and units of general local government,
Indian tribes, and insular areas, unless
provided otherwise by supplemental
appropriations statute, based on their
unmet disaster recovery needs.
The Neighborhood Stabilization
Program (NSP) was established for the
purpose of stabilizing communities that
have suffered as a result of foreclosures
and property abandonment. On July 21,
2010, President Obama signed the
Dodd-Frank Wall Street Reform and
Consumer Protection Act (Dodd-Frank
Act) into law (Pub. L. 111–203). This
law provides $1 billion of formula grant
funding for the redevelopment of
foreclosed and abandoned homes to be
allocated under the terms of Title XII,
Division A, Section 2 of the American
Recovery and Reinvestment Act
(Recovery Act) and by the formula
factors provided in Title III of Division
B of the Housing and Economic
Recovery Act of 2008 (Pub. L. 110–289)
(HERA). In 2008, HERA provided for an
initial round of formula funding to
regular State and entitlement
Community Development Block Grant
(CDBG) grantees through the
Neighborhood Stabilization Program
(NSP1).1 The Recovery Act provided for
a neighborhood stabilization grant
competition open to state and local
governments, as well as non-profit
groups and consortia that may include
for-profit entities (NSP2).2 The DoddFrank Act is the third round of
Neighborhood Stabilization Funding
(NSP3). Although NSP funds are
otherwise to be considered CDBG funds,
HERA, the Recovery Act and the DoddFrank Act make substantive revisions to
the eligibility, use, and method of
distribution of NSP3 funds. For NSP1
and NSP3, grantees are required to
submit substantial amendments to their
consolidated plans to secure funding
they are entitled to under the formula
grants. NSP3 Technical Assistance
grants were appropriated under DoddFrank Wall Street Reform and Consumer
Protection Act (Dodd-Frank Act) (Pub.
L. 111–203). Grantees were selected
through a competitive process set forth
in the NSP3–TA Notice of Funding
Availability (NOFA),3 with the purpose
of assessing the need for technical
assistance and targeting technical
assistance in order to achieve the
highest level of performance and results
for the programs administered by HUD’s
Office of Community Planning and
Development. Eligible applicants
include states, units of local
government, public housing authorities,
E:\FR\FM\12SEN1.SGM
12SEN1
]]>Agencies
[Federal Register Volume 77, Number 177 (Wednesday, September 12, 2012)]
[Notices]
[Pages 56216-56217]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-22385]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Oncology 1-Basic Translational Integrated
Review Group; Cancer Etiology Study Section.
Date: October 11, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance Long Beach Hotel, 111 East Ocean Blvd., Long
Beach, CA 90802.
Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184, MSC 7804, Bethesda, MD
20892, 301-435-1779, riverase@csr.nih.gov.
Name of Committee: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences Integrated Review Group; Integrative and
Clinical Endocrinology and Reproduction Study Section.
Date: October 11, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Dianne Hardy, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6175, MSC 7892, Bethesda, MD 20892, 301-435-
1154, dianne.hardy@nih.gov.
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group; Gastrointestinal Mucosal Pathobiology Study
Section.
Date: October 11-12, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Peter J. Perrin, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD
20892, (301) 435-0682, perrinp@csr.nih.gov.
Name of Committee: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences Integrated Review Group; Cellular Aspects of
Diabetes and Obesity Study Section.
Date: October 11-12, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance Long Beach Hotel, 111 East Ocean Blvd., Long
Beach, CA 90802.
Contact Person: Robert Garofalo, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institute of Health,
6701 Rockledge Drive, Room 6156, MSC 7892, Bethesda, MD 20892, 301-
435-1043, garofalors@csr.nih.gov.
Name of Committee: Bioengineering Sciences & Technologies
Integrated Review Group; Biodata Management and Analysis Study
Section.
Date: October 11-12, 2012.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center,
Bethesda, MD 20892.
Contact Person: Mark Caprara, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5156, MSC 7844, Bethesda, MD 20892, 301-435-
1042, capraramg@mail.nih.gov.
Name of Committee: Bioengineering Sciences & Technologies
Integrated Review Group; Modeling and Analysis of Biological Systems
Study Section.
Date: October 11-12, 2012
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bolger Center, 9600 Newbridge Drive, Potomac, MD 20854.
Contact Person: Craig Giroux, Scientific Review Officer, BST
IRG, Center for Scientific Review, National Institutes of Health,
6701 Rockledge Drive, Room 5150, Bethesda, MD 20892, 301-435-2204,
girouxcn@csr.nih.gov.
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group; Neural Oxidative Metabolism
and Death Study Section.
Date: October 11-12, 2012.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: Loews L'Enfant Plaza Hotel, 480 L'Enfant Plaza SW.,
Washington, DC 20024-2197.
Contact Person: Carol Hamelink, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192, MSC 7850, Bethesda, MD
20892, (301) 213-9887, hamelinc@csr.nih.gov.
Name of Committee: Cell Biology Integrated Review Group;
Molecular and Integrative Signal Transduction Study Section.
Date: October 11-12, 2012.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
[[Page 56217]]
Place: Mayflower Park Hotel, 405 Olive Way, Seattle, WA 98101.
Contact Person: Raya Mandler, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5134, MSC 7840, Bethesda, MD 20892, (301) 402-
8228, rayam@csr.nih.gov.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group; Neurobiology of Motivated
Behavior Study Section.
Date: October 11, 2012.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate grant applications.
Place: Spring Hill Suites New Orleans Downtown, New Orleans, LA
70130.
Contact Person: Nicholas Gaiano, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5178, MSC 7844, Bethesda, MD 20892-7844, 301-
435-1033, gaianonr@csr.nih.gov.
Name of Committee: Immunology Integrated Review Group; Vaccines
Against Microbial Diseases Study Section.
Date: October 11-12, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Marriott, 1221 22nd Street NW., Washington, DC
20037.
Contact Person: Jian Wang, MD, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4218, MSC 7812, Bethesda, MD 20892, (301) 435-
2778, wangjia@csr.nih.gov.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group; Mechanisms of Sensory,
Perceptual, and Cognitive Processes Study Section.
Date: October 11-12, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Springhill Suites New Orleans Downtown, 301 St. Joseph
St, New Orleans, LA 70130.
Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301-435-
1242, kgt@mail.nih.gov.
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Brain Injury and Neurovascular Pathologies
Study Section.
Date: October 11-12, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: New Orleans Marriott at the Convention Center, 859
Convention Center Boulevard, New Orleans, LA 70130.
Contact Person: Alexander Yakovlev, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5206, MSC 7846, Bethesda, MD
20892, 301-435-1254, yakovleva@csr.nih.gov.
Name of Committee: Oncology 1-Basic Translational Integrated
Review Group; Tumor Progression and Metastasis Study Section.
Date: October 11-12, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria,
VA 22314.
Contact Person: Rolf Jakobi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6187, MSC 7806, Bethesda, MD 20892, 301-495-
1718, jakobir@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 6, 2012.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-22385 Filed 9-11-12; 8:45 am]
BILLING CODE 4140-01-P
